Company: CERO
Filing Date: 2025-04-25
Form Type: 8-K
Source: 0001213900-25-035535
Chunk: 2

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-25
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01
Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                           
  3.1†             Certificate of Designation of Preferences, Rights and Limitations of the Series D Convertible Preferred Stock, dated April 22, 2025.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  99.1             Investor Presentation, dated April 2025.                                                                                              
  104              Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                          

  Certain portions of this document that constitute confidential                 

SIGNATURES